Search Results

There are 14314 results for: content related to: Frequency and nature of drug-drug interactions in the intensive care unit

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >
  1. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1202–1215, Vincent Lo Re III, Kevin Haynes, Eileen E. Ming, Jennifer Wood Ives, Laura N. Horne, Kimberly Fortier, Dena M. Carbonari, Sean Hennessy, Serena Cardillo, Peter P. Reese, K. Rajender Reddy, David Margolis, Andrea Apter, Stephen E. Kimmel, Jason Roy, Cristin P. Freeman, Hanieh Razzaghi, Crystal N. Holick, Daina B. Esposito, Tjeerd-Pieter Van Staa, Harshvinder Bhullar and Brian L. Strom

    Article first published online : 4 JUL 2012, DOI: 10.1002/pds.3318

  2. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database

    Pharmacoepidemiology and Drug Safety

    Wen-Shyong Liou, Shu-Ching Hsieh, Wai-Yuan Chang, Grace Hui-Min Wu, Hsu-Shan Huang and Chuanfang Lee

    Article first published online : 29 APR 2013, DOI: 10.1002/pds.3445

  3. Utilisation of transdermal fentanyl in Germany from 2004–2006 by Edeltraut Garbe and colleagues

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 902–903, Rainer Sabatowski and Rüdiger Scharnagel

    Article first published online : 26 JUL 2012, DOI: 10.1002/pds.3315

  4. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  5. Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 494–506, Christopher G. Rowan, Steven M. Brunelli, Jeffrey Munson, James Flory, Peter P. Reese, Sean Hennessy, James Lewis, Daniel Mines, Jeffrey S. Barrett, Warren Bilker and Brian L. Strom

    Article first published online : 16 MAR 2012, DOI: 10.1002/pds.3199

  6. You have free access to this content
    Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S2, May 2012, Pages: 60–68, Menggang Yu, Dawei Xie, Xingmei Wang, Mark G. Weiner and Richard L. Tannen

    Article first published online : 3 MAY 2012, DOI: 10.1002/pds.3235

  7. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1155–1172, Charles E. Leonard, Cristin P. Freeman, Craig W. Newcomb, Peter P. Reese, Maximilian Herlim, Warren B. Bilker, Sean Hennessy and Brian L. Strom

    Article first published online : 9 AUG 2012, DOI: 10.1002/pds.3329

  8. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Article first published online : 17 APR 2013, DOI: 10.1002/pds.3432

  9. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 4, April 2013, Pages: 335–344, Sharon K. Greene, Lingling Li, David K. Shay, Alicia M. Fry, Grace M. Lee, Steven J. Jacobsen, Roger Baxter, Stephanie A. Irving, Michael L. Jackson, Allison L. Naleway, James D. Nordin, Komal J. Narwaney and Tracy A. Lieu

    Article first published online : 5 NOV 2012, DOI: 10.1002/pds.3363

  10. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 835–843, Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert and Olaf H. Klungel

    Article first published online : 6 JUN 2012, DOI: 10.1002/pds.3291

  11. Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 5, May 2013, Pages: 447–458, Suzanne L. West, Linda B. Squiers, Lauren McCormack, Brian G. Southwell, Emily S. Brouwer, Mahima Ashok, Linda Lux, Vanessa Boudewyns, Amie O'Donoghue and Helen W. Sullivan

    Article first published online : 26 FEB 2013, DOI: 10.1002/pds.3416

  12. Utilization and costs of conventional and alternative pharmaceuticals in children: results from the German GINIplus and LISAplus birth cohort studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1102–1111, Salvatore Italia, Ariane Batscheider, Joachim Heinrich, Christina Wenig, Carl Peter Bauer, Sibylle Koletzko, Irina Lehmann, Olf Herbarth, Andrea von Berg, Dietrich Berdel, Barbara Hoffmann, Beate Schaaf and Silke B. Wolfenstetter

    Article first published online : 31 JUL 2012, DOI: 10.1002/pds.3323

  13. Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997–2007

    Pharmacoepidemiology and Drug Safety

    Jennifer N. Lind, Sarah C. Tinker, Cheryl S. Broussard, Jennita Reefhuis, Suzan L. Carmichael, Margaret A. Honein, Richard S. Olney, Samantha E. Parker and Martha M. Werler, for the National Birth Defects Prevention Study

    Article first published online : 26 APR 2013, DOI: 10.1002/pds.3448

  14. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 507–514, Marloes T. Bazelier, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Peter Vestergaard and Frank de Vries

    Article first published online : 6 MAR 2012, DOI: 10.1002/pds.3234

  15. Electronic healthcare databases for active drug safety surveillance: is there enough leverage?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 6, June 2012, Pages: 611–621, Preciosa M. Coloma, Gianluca Trifirò, Martijn J. Schuemie, Rosa Gini, Ron Herings, Julia Hippisley-Cox, Giampiero Mazzaglia, Gino Picelli, Giovanni Corrao, Lars Pedersen, Johan van der Lei and Miriam Sturkenboom, on behalf of the EU-ADR consortium

    Article first published online : 8 FEB 2012, DOI: 10.1002/pds.3197

  16. You have free access to this content
    Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 1, January 2013, Pages: 40–54, Sarah L. Cutrona, Sengwee Toh, Aarthi Iyer, Sarah Foy, Gregory W. Daniel, Vinit P. Nair, Daniel Ng, Melissa G. Butler, Denise Boudreau, Susan Forrow, Robert Goldberg, Joel Gore, David McManus, Judith A. Racoosin and Jerry H. Gurwitz

    Article first published online : 29 JUN 2012, DOI: 10.1002/pds.3310

  17. Impact of physician preferences for homeopathic or conventional medicines on patients with musculoskeletal disorders: results from the EPI3-MSD cohort

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1093–1101, Michel Rossignol, Bernard Begaud, Pierre Engel, Bernard Avouac, France Lert, Frederic Rouillon, Jacques Bénichou, Jacques Massol, Gerard Duru, Anne-Marie Magnier, Didier Guillemot, Lamiae Grimaldi-Bensouda and Lucien Abenhaim, for the EPI3-LA-SER group

    Article first published online : 11 JUL 2012, DOI: 10.1002/pds.3316

  18. Administered paricalcitol dose and survival in hemodialysis patients: A marginal structural model analysis

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1232–1239, Jessica E Miller, Miklos Z Molnar, Csaba P Kovesdy, Joshua J Zaritsky, Elani Streja, Isidro Salusky, Onyebuchi A Arah and Kamyar Kalantar-Zadeh

    Article first published online : 20 SEP 2012, DOI: 10.1002/pds.3349

  19. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 5, May 2013, Pages: 459–467, José Luis Oliveira, Pedro Lopes, Tiago Nunes, David Campos, Scott Boyer, Ernst Ahlberg, Erik M. van Mulligen, Jan A. Kors, Bharat Singh, Laura I. Furlong, Ferran Sanz, Anna Bauer-Mehren, Maria C. Carrascosa, Jordi Mestres, Paul Avillach, Gayo Diallo, Carlos Díaz Acedo and Johan van der Lei

    Article first published online : 4 DEC 2012, DOI: 10.1002/pds.3375

  20. Propoxyphene and the risk of out-of-hospital death

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 4, April 2013, Pages: 403–412, Wayne A. Ray, Katherine T. Murray, Vivian Kawai, David J. Graham, William O. Cooper, Kathi Hall and Charles Michael Stein

    Article first published online : 14 FEB 2013, DOI: 10.1002/pds.3411

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >